Table of Contents
Cover image

FEATURED ARTICLE
18F-Fluoroestradiol PET Imaging in a Phase II Trial of Vorinostat to Restore Endocrine Sensitivity in ER+/HER2– Metastatic Breast Cancer. Lanell Peterson et al. See page 184.
Increasing tumor immunogenicity: combined 225Ac-PSMA–targeted radionuclide and immune therapies in prostate cancer. Johannes Czernin et al. See page 228.